Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 1 Month to 59 Months

Managing shock in malnourished children with diarrhea

Official title: Randomized Controlled Trial of Dopamine, Adrenaline, and Blood Transfusion for Treatment of Fluid Refractory Shock in Children With Severe Acute Malnutrition or Severe Underweight and Cholera or Other Dehydrating Diarrheas

Run by International Centre for Diarrhoeal Disease Research, Bangladesh · NCT04750070 · Data updated 2026-11-12

This study is testing whether blood transfusions and certain medications can help young children with severe malnutrition and diarrhea who are in shock feel better compared to regular fluid treatments.

Quick facts

PhasePhase 3
Study typeInterventional
Ages1 Month to 59 Months
SexAll
Enrollment135 (estimated)
SponsorInternational Centre for Diarrhoeal Disease Research, Bangladesh
Academic / other
Locations1 site (Dhaka)
StatusRecruiting
StartedAugust 17, 2021
Main results expectedJuly 31, 2025
Study endsNovember 30, 2025
Registry record updatedApril 16, 2025
Trial IDNCT04750070 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 1-59 months with acute malnutrition and diarrhea who are experiencing fluid refractory shock.

Probably not a fit

Patients who are in need of immediate cardiopulmonary resuscitation or have rare blood types without available donors may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of blood transfusions and vasoactive medications like dopamine and adrenaline in treating children aged 1-59 months who are suffering from severe acute malnutrition and experiencing fluid refractory shock due to diarrhea. The study aims to address the high mortality rates associated with severe sepsis and septic shock in this vulnerable population, particularly in the context of existing WHO treatment guidelines. By comparing conventional fluid therapy with these alternative interventions, the trial seeks to fill a critical knowledge gap regarding optimal management strategies for these children.

Why it matters

Potential benefit: If successful, this study could significantly reduce mortality rates in malnourished children suffering from shock due to diarrhea.

How similar studies have gone: While similar studies have highlighted the challenges of managing severe sepsis in malnourished children, this specific approach involving inotropes and blood transfusions in the context of dehydrating diarrhea is novel and has not been systematically evaluated before.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Children of either sex with acute malnutrition and diarrhea
2. Age: 1-59 months
3. Children with cerebral palsy (CP) and/or developmental delay, Down Syndrome with or without heart diseases
4. Fluid refractory shock
5. Consent from the caregivers/parents

Exclusion Criteria:

1. Having a rare blood group (Rh negative blood groups provided that donor is not available)
2. A child requiring cardio-pulmonary resuscitation during screening or having gasping respiration

Where it's running

  • Icddr,B
    Dhaka, Bangladesh
    Recruiting

Study contacts

  • Principal investigator: Tahmeed Ahmed, PhD — International Centre for Diarrhoeal Disease Research, Bangladesh
  • Study coordinator: Monira Sarmin, MBBS, MCPS
  • Email: drmonira@icddrb.org
  • Phone: +8801718596947

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Blood Transfusion Factors and Cell Saver Use in Kids’ Spine Surgery

    This study looks at which factors put pediatric scoliosis patients at risk for needing donor blood during posterior spinal fusion and how using a Cell Saver during surgery might reduce that need.

    Recruiting Tunis University · Tunis · NCT07661589

  • Timing of hip fracture surgery for patients on DOAC blood thinners

    This project will see if operating within 24 hours is as safe as delaying surgery for people with hip fractures who recently took DOAC blood thinners by comparing how often they need blood transfusions.

    Recruiting at 7 sites St. Antonius Hospital · Almelo and 6 other locations · NCT07309848

  • Identifying Photoplethysmographic Waves in Adults with Septic Shock

    This study is trying to see what different types of blood flow signals look like in adults with septic shock and how they relate to signs of poor blood circulation.

    Recruiting Hospital General de México Dr. Eduardo Liceaga · Mexico City, Cuauhtemoc · NCT06786364

  • Predicting blood needs and hemolysis risk in children having heart surgery

    This project will collect blood samples from children having heart surgery to try to build a mathematical model that predicts transfusion needs and hemolysis risk during surgery.

    Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT06721455

  • Guided transfusion strategy for critically ill patients

    This study is testing a personalized blood transfusion approach for critically ill patients to see if it can improve their chances of recovery compared to standard practices.

    Recruiting at 4 sites Università degli Studi di Ferrara · Brussels and 3 other locations · NCT06102590

  • Targeted resuscitation approach for septic shock patients

    This study tests a personalized treatment plan for people with septic shock to see if using specific signs like capillary refill time can help them recover better than standard methods.

    Recruiting Assistance Publique - Hôpitaux de Paris · Reims · NCT06062303

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.